Pharmocann develops and produces Israeli medical cannabis on a farm located in the valley of Jezreel, the Galilee. The farm has hothouses for cannabis growth and propagation; a hothouse for the research and development of various cannabis strains; and other facilities required for the cultivation, harvesting, and production of medical cannabis.
The company is also a developer of medical marijuana cultivation centers and dispensaries. Pharmocann has established a strategic partnership with medical cannabis labs to produce standardized, validated, and GMP-manufactured medical cannabis products. Its line of products includes oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.
Pharmocann’s latest developments include hydrogel products for the treatment of certain painful diseases, acute dermatological diseases, and inflammatory bowl diseases. Pharmocann serves more than 3,000 patients a month and yields about two tons of medical cannabis yearly.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Pharmocann Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Sep 14, 2022
www.sponser.co.il
ספונסר תקלה
#Investment
Sep 13, 2022
www.calcalist.co.il
פארמוקן מנפיקה במחירי סוף עונה והמניה התרסקה ב־27% | כלכליסט
#Investment, Layoffs
Jul 17, 2022
www.globes.co.il
פטרייה חדרה לקנאביס של פארמוקן; המנכ"ל עזב במפתיע
#Management Changes
Apr 28, 2022
www.sponser.co.il
פארמוקן מרחיבה את כושר הייצור
#Partners
Nov 18, 2021
www.calcalist.co.il
קנאביס, טייק 2: פרופ' זאב רוטשטיין יעמוד גם בראש פארמוקן כלכליסט